Finance

Beta
Lists
YSWY:NASDAQ
Yesway Inc
$20.71
-4.21%
(-0.91) 1D
Jun 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for YSWY...
Open
$21.48
High
$21.90
Low
$20.31
Mkt. cap
1.31B
Avg. vol.
461.08K
Volume
359.69K
P/E ratio
14.05
52-wk high
$29.08
52-wk low
$19.20
EPS
$1.47
No. of employees
4K
Open
$21.48
High
$21.90
Low
$20.31
Mkt. cap
1.31B
Avg. vol.
461.08K
Volume
359.69K
P/E ratio
14.05
52-wk high
$29.08
52-wk low
$19.20
EPS
$1.47
No. of employees
4K
News stories
From sources across the web
About Yesway Inc
CEO-
Employees4.11K
Founded2015
HeadquartersFort Worth, Texas, United States
SectorConsumer
Websiteyesway.com
Analyst Ratings
Based on 8 analysts giving stock ratings to YSWY in the past 3 months
Buy
Buy
5
Hold
3
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for YSWY in the last 3 months.
Highest
Current $20.71
$31.00 (+49.69%)
Average
$29.13 (+40.66%)
Lowest
$25.00 (+20.71%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Thomas Palmer
J.P. Morgan
Hold
Reiterated
$25.00
+20.7%
06/05/2026
Bonnie Herzog
Goldman Sachs
Hold
Maintained
$28.00
+35.2%
06/02/2026
John Heinbockel
Guggenheim
Buy
Reiterated
$30.00
+44.9%
06/03/2026
Simeon Gutman
Morgan Stanley
Hold
Maintained
$28.00
+35.2%
06/03/2026
Kelly Bania
BMO Capital
Buy
Maintained
$30.00
+44.9%
06/02/2026
Seth Sigman
Barclays
Buy
Reiterated
$31.00
+49.7%
06/03/2026
Bradley Thomas
KeyBanc
Buy
Reiterated
$31.00
+49.7%
06/03/2026
Bobby Griffin
Raymond James
Buy
Initiated
$30.00
+44.9%
05/18/2026
Last report
Jun 2, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
- / $0.45
Revenue / Est. (USD)
624.66M / 679.11M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Dec 2025
Mar 2026
Revenue
611.07M
546.00M
678.70M
624.66M
Cost of goods sold
501.90M
431.03M
542.25M
474.90M
Cost of revenue
501.90M
431.03M
542.25M
474.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
68.94M
87.20M
80.41M
90.51M
Operating expense
84.84M
102.71M
96.37M
106.50M
Total operating expenses
586.74M
533.75M
638.62M
581.40M
Operating income
24.33M
12.26M
40.08M
43.26M
Other non operating income
2.00M
-1.30M
-
-
EBT including unusual items
5.15M
-5.63M
19.59M
30.24M
EBT excluding unusual items
10.61M
-3.58M
26.25M
31.05M
Income tax expense
-16.00K
-
-
-
Effective tax rate
-0.31%
-
-
-
Other operating expenses
-
-
-
-
Net income
5.16M
-5.63M
19.59M
30.24M
Net profit margin
0.85%
-1.03%
2.89%
4.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-15.72M
-14.53M
-13.82M
-12.21M
Net interest expenses
-15.72M
-14.53M
-13.82M
-12.21M
Depreciation and amortization charges
15.91M
15.52M
15.96M
15.99M
EBITDA
40.23M
27.77M
56.03M
59.25M
Gain or loss from assets sale
650.00K
-745.00K
-137.00K
-86.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer